Strategies of LncRNA DLX6-AS1 on Study and Therapeutics
Accumulating evidence has revealed the vital regulatory roles of lncRNA DLX6-AS1 in various tumors at pre-transcriptional, transcriptional, and post-transcriptional levels, which makes it a potential prognosis factor and therapeutic target. In addition, the presence of lncRNA DLX6-AS1 in the exosome...
Main Authors: | Yanyan Zhao, Pei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.871988/full |
Similar Items
-
LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1
by: Feng-Chih Kuo, et al.
Published: (2022-12-01) -
The lncRNA DLX6-AS1/miR-16-5p axis regulates autophagy and apoptosis in non-small cell lung cancer: A Boolean model of cell death
by: Shantanu Gupta, et al.
Published: (2023-12-01) -
Current insights into the molecular systems pharmacology of lncRNA-miRNA regulatory interactions and implications in cancer translational medicine
by: Sujit Nair
Published: (2016-04-01) -
Editorial: lncRNA in plants: function, mechanisms and applications
by: Jun Cui
Published: (2023-06-01) -
Analyses of lncRNA and mRNA profiles in recurrent atrial fibrillation after catheter ablation
by: Huaiguang Tang, et al.
Published: (2024-04-01)